SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001999371-24-004134
Filing Date
2024-03-28
Accepted
2024-03-28 17:06:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13D gsk-sc13da_032524.htm SC 13D/A 50861
  Complete submission text file 0001999371-24-004134.txt   52646
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GSK plc (Filed by) CIK: 0001131399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 (925) 407-1049
Nkarta, Inc. (Subject) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91570 | Film No.: 24800215
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)